The importance of genetic background on pain behaviours and pharmacological sensitivity in the rat spared serve injury model of peripheral neuropathic pain

European Journal of Pharmacology

Volumn 564, Issue 1-3, 2007, Pages 103-111

  Rode, Frederik ^a   Thomsen, Mads ^a   Broløs, Tine ^a   Jensen, Dorthe G ^a   Blackburn Munro, Gordon ^b   Bjerrum, Ole J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

Gabapentin; Gaboxadol; Morphine; Pain; Pharmacogenetic; Spared nerve injury; Strain

Indexed keywords

GABAPENTIN; GABOXADOL; MORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN NORWAY RAT; CONTROLLED STUDY; DRUG SENSITIVITY; FISCHER 344 RAT; HEREDITY; HYPERSENSITIVITY; LEWIS RAT; MALE; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT;

AMINES; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; HINDLIMB; ISOXAZOLES; MALE; MORPHINE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVES; PHARMACOGENETICS; RATS; RATS, INBRED BN; RATS, INBRED F344; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY;

EID: 34250683783     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.009     Document Type: Article

References (50)

1. Backonja M.M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 59 (2002) S14-S17
2. Belknap J.K., Mogil J.S., Helms M.L., Richards S.P., O'Toole L.A., Bergeson S.E., and Buck K.J. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. Life Sci. 57 (1995) L117-L124
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Bergeson S.E., Helms M.L., O'Toole L.A., Jarvis M.W., Hain H.S., Mogil J.S., and Belknap J.K. Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm. Genome 12 (2001) 546-553
5. Blackburn-Munro G. Pain-like behaviours in animals-how human are they?. Trends Pharmacol. Sci. 25 (2004) 299-305
6. Bulka A., Wiesenfeld-Hallin Z., and Xu X.J. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan. Brain Res. 942 (2002) 95-100
7. Bulka A., Kouya P.F., Bottiger Y., Svensson J.O., Xu X.J., and Wiesenfeld-Hallin Z. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats. Eur. J. Pharmacol. 492 (2004) 27-34
8. Caldji C., Diorio J., Anisman H., and Meaney M.J. Maternal behavior regulates benzodiazepine/GABAA receptor subunit expression in brain regions associated with fear in BALB/c and C57BL/6 mice. Neuropsychopharmacology 29 (2004) 1344-1352
9. Carr M.M., Best T.J., Mackinnon S.E., and Evans P.J. Strain differences in autotomy in rats undergoing sciatic nerve transection or repair. Ann. Plast. Surg. 28 (1992) 538-544
10. Chesler E.J., Ritchie J., Kokayeff A., Lariviere W.R., Wilson S.G., and Mogil J.S. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain 106 (2003) 325-335
11. Cook C.D., Barrett A.C., Roach E.L., Bowman J.R., and Picker M.J. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology (Berl) 150 (2000) 430-442
12. Decosterd I., and Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87 (2000) 149-158
13. Decosterd I., Allchorne A., and Woolf C.J. Differential analgesic sensitivity of two distinct neuropathic pain models. Anesth. Analg. 99 (2004) 457-463 (table)
14. Devor M., and Raber P. Heritability of symptoms in an experimental model of neuropathic pain. Pain 42 (1990) 51-67
15. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., Bushnell M.C., Farrar J.T., Galer B.S., Haythornthwaite J.A., Hewitt D.J., Loeser J.D., Max M.B., Saltarelli M., Schmader K.E., Stein C., Thompson D., Turk D.C., Wallace M.S., Watkins L.R., and Weinstein S.M. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60 (2003) 1524-1534
16. Erichsen H.K., and Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 98 (2002) 151-161
17. Erichsen H.K., Hao J.X., Xu X.J., and Blackburn-Munro G. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Pain 116 (2005) 347-358
18. Festing, M.F.W., 2003. Laboratory animal genetics and genetic quality control. 2nd, 173-203.
19. Finn D.A., Long S.L., Tanchuck M.A., and Crabbe J.C. Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol. Biochem. Behav. 78 (2004) 435-443
20. Flores C.M., and Mogil J.S. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management. Pharmacogenomics 2 (2001) 177-194
21. Hain H.S., Belknap J.K., and Mogil J.S. Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine (Serotonin)-1B receptors in the mediation of morphine antinociceptive sensitivity. J. Pharmacol. Exp. Ther. 291 (1999) 444-449
22. Hansson P. Neuropathic pain: clinical characteristics and diagnostic workup. Eur. J. Pain 6 Suppl A (2002) 47-50
23. Jensen T.S., and Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102 (2003) 1-8
24. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
25. Klepstad P., Dale O., Skorpen F., Borchgrevink P.C., and Kaasa S. Genetic variability and clinical efficacy of morphine. Acta Anaesthesiol. Scand. 49 (2005) 902-908
26. Laughlin T.M., Tram K.V., Wilcox G.L., and Birnbaum A.K. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J. Pharmacol. Exp. Ther. 302 (2002) 1168-1175
27. Lawson S.N. Phenotype and function of somatic primary afferent nociceptive neurones with C-, Adelta- or Aalpha/beta-fibres. Exp. Physiol. 87 (2002) 239-244
28. Lovell J.A., Stuesse S.L., Cruce W.L., and Crisp T. Strain differences in neuropathic hyperalgesia. Pharmacol. Biochem. Behav. 65 (2000) 141-144
29. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C.I., and Myers R.R. Injury type-specific calcium channel alpha(2)delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Ther. 303 (2002) 1199-1205
30. Mogil J.S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7744-7751
31. Mogil J.S., and Adhikari S.M. Hot and cold nociception are genetically correlated. J. Neurosci. 19 (1999) RC25
32. Mogil J.S., Wilson S.G., Bon K., Lee S.E., Chung K., Raber P., Pieper J.O., Hain H.S., Belknap J.K., Hubert L., Elmer G.I., Chung J.M., and Devor M. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80 (1999) 67-82
33. Morgan D., Cook C.D., and Picker M.J. Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor. J. Pharmacol. Exp. Ther. 289 (1999) 965-975
34. Pedersen L.H., Nielsen A.N., and Blackburn-Munro G. Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology (Berl) 182 (2005) 551-561
35. Rode F., Jensen D.G., Blackburn-Munro G., and Bjerrum O.J. Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur. J. Pharmacol. 516 (2005) 131-138
36. Rose M.A., and Kam P.C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 57 (2002) 451-462
37. Rudolph U., Crestani F., and Mohler H. GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol. Sci. 22 (2001) 188-194
38. Selley D.E., Herbert J.T., Morgan D., Cook C.D., Picker M.J., and Sim-Selley L.J. Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain. Brain Res. Bull. 60 (2003) 201-208
39. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
40. Shelton K.L., and Grant K.A. Discriminative stimulus effects of ethanol in C57BL/6J and DBA/2J inbred mice. Alcohol Clin. Exp. Res. 26 (2002) 747-757
41. Shir Y., Zeltser R., Vatine J.J., Carmi G., Belfer I., Zangen A., Overstreet D., Raber P., and Seltzer Z. Correlation of intact sensibility and neuropathic pain-related behaviors in eight inbred and outbred rat strains and selection lines. Pain 90 (2001) 75-82
42. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
43. Smith S.B., Crager S.E., and Mogil J.S. Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains. Life Sci. 74 (2004) 2593-2604
44. Su T.Z., Lunney E., Campbell G., and Oxender D.L. Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J. Neurochem. 64 (1995) 2125-2131
45. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., and Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29 (1998) 233-249
46. Wilson S.G., Smith S.B., Chesler E.J., Melton K.A., Haas J.J., Mitton B., Strasburg K., Hubert L., Rodriguez-Zas S.L., and Mogil J.S. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics. J. Pharmacol. Exp. Ther. 304 (2003) 547-559
47. Woolf C.J., Bennett G.J., Doherty M., Dubner R., Kidd B., Koltzenburg M., Lipton R., Loeser J.D., Payne R., and Torebjork E. Towards a mechanism-based classification of pain?. Pain 77 (1998) 227-229
48. Xu X.J., Hao J.X., Aldskogius H., Seiger A., and Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain 48 (1992) 279-290
49. Yoon Y.W., Lee D.H., Lee B.H., Chung K., and Chung J.M. Different strains and substrains of rats show different levels of neuropathic pain behaviors. Exp. Brain Res. 129 (1999) 167-171
50. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110